Eight Advisory advised SERB Pharmaceuticals on its acquisition of Y-mAbs Therapeutics
Eight Advisory and Eight Advisory Avocats conducted the financial and tax due diligences, as well as the tax modeling, on behalf of SERB Pharmaceuticals as part of this transaction.
Eight Advisory team members supporting this transaction:
- Financial due diligence: Edouard Decamp (Partner), Louis Legros (Director), Archer Tawney (Manager)
Eight Advisory Avocats team members supporting this transaction:
- Tax due diligence and tax modeling review: Guillaume Rembry (Partner-Attorney at law), Guillaume Exerjean (Attorney at law), Lucie Goeller (Attorney at law)
Deals
Eight Advisory advised Groupe Rocher on the sale of Petit Bateau to Regent Capital Partners
4 Sep 2025
Read more